Company intelligence / Profile preview

Relief Cardiovascular

Durham, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

Relief Cardiovascular was a development-stage medical device company specializing in interventional cardiology solutions. The company was primarily focused on the development of a percutaneous heart valve system intended for the treatment of aortic stenosis. Founded by Dr. Richard Stack and incubated within the Synecor life sciences accelerator, Relief Cardiovascular aimed to advance transcatheter aortic valve replacement (TAVR) technologies. The company's innovative approach to structural heart disease led to its acquisition by Boston Scientific in 2006. This acquisition was a strategic move by Boston Scientific to expand its presence in the emerging TAVR market.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Relief Cardiovascular.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relief Cardiovascular.

Explore the full profile